How does Critical Path research and science differ from investments in biomedical and translational research made by the Department of Health and Human Services, for example, through NIH research?
Critical Path science is the applied science partner of biomedical discovery science, and a productivity multiplier for our investments in basic and translational research. Critical Path research is complementary to basic and translational research, but dedicated to downstream product development concerns. All basic sciences need a corresponding applied science to turn concepts and prototypes into useful products. Critical Path science is highly pragmatic and targeted on identified biomedical science problems that are causing delays in product development. By eliminating bottlenecks in product development, Critical Path science will allow us to realize more of the value of our investments in biomedical discovery research, in the form of more new products. Without answers to these questions for our new biomedical discoveries, they will remain as discoveries.
Related Questions
- How does Critical Path research and science differ from investments in biomedical and translational research made by the Department of Health and Human Services, for example, through NIH research?
- What Masters courses are available within the Research Department of Clinical, Educational and Health Psychology?
- Why Consumer Advocates?
